D-0672-2026 Class II Ongoing
FDA drug recall D-0672-2026 was initiated by Reliance Life Sciences Private Limited on Jun 24, 2026 and is designated Class II. Reason for recall: Lack of Sterility Assurance The recall status is ongoing. Affected quantity: 5,020 vials.
Recall details
- Product Type
- Drugs
- Report Date
- Jul 15, 2026
- Initiation Date
- Jun 24, 2026
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 5,020 vials
Product description
Pemetrexed for Injection 500mg/Vial, 1 50 mL Single-Dose Vial per carton, For intravenous use only, Rx only, Manufactured for: Somerset Therapeutics, LLC., Somerset, NJ 08873 NDC: 70069-0835-01
Reason for recall
Lack of Sterility Assurance
Distribution pattern
Nationwide in the USA
Code information
Lot, expiry: RPTH0125A Jan 31, 2028; RPTH0225A Jan 31, 2028; RPTH0325A Jan 31, 2028; RPTH0725A Apr 30, 2028;
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0672-2026
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026